From the Editor:

Max Buja, Editor

 

May/June 2014 Issue (Volume 23, Number 3)

With the arrival of the May/June issue, half of the Volume 23, 2014 issues of Cardiovascular Pathology will have been published in full (print and electronic). The publication of this issue also marks my completion of two and a half years since I officially assumed the role of Editor-in-Chief of the Journal (after a six month transition period working with the previous editors). Time flies when you are busy and having fun if you think that being a journal editor is fun.

We now have essentially complete final disposition data for the six issues of Volume 22, published in 2013. In 2013, we processed 222 manuscripts. We accepted 53 for an overall acceptance rate of 24%, including 31 (25%) of 126 original full length articles, 7 (41%) of 17 review articles, 9 (14%) of 66 case reports and image presentations, and 6 (46%) of 13 other manuscripts (letters, editorials, historical perspectives and an obituary)..

In the first three issues of Volume 23, 2014, we have published 33 articles, comprising 5 review articles, 17 full length original articles, 5 clinical case reports, 3 image articles, 2 historical perspectives and 1 obituary. The review articles include 3 general reviews and 2 in our occasional series on Innovative Cardiovascular Pathology, Pathobiology, Interventions and Technologies. The full length original articles have a nearly equal balance between studies derived from human subjects (9) and experimental research (8).

With the significant and essential contributions of our editorial board members and reviewers, we accept articles for publication striving to meet the mission of the Journal presented on the CVP web site.

The lead statement is:

Cardiovascular Pathology

A Journal of Basic, Clinical and Applied Cardiovascular Science

The Official Journal of the Society for Cardiovascular Pathology

Cardiovascular Pathology is a bimonthly journal that presents articles on topics covering the entire spectrum of cardiovascular disease. The Journal's primary objective is to publish papers on disease-oriented morphology and pathogenesis from clinicians and scientists in the cardiovascular field. Subjects covered include cardiovascular biology, prosthetic devices, molecular biology and experimental models of cardiovascular disease. Cardiovascular Pathology also publishes timely and informative reviews on scientific areas in cardiovascular pathology as well as case reports that represent significant or unique observations.

Elsevier has produced a very informative web page for our CVP Journal. I recommend that you add the CVP website to your favorite bookmarks. You can also access it from the SCVP home page. There you will find and be able to access recently accepted articles in press, recent open access articles, most cited articles and most downloaded articles. You will also see our current impact factor as well as access to information, including guidelines for authors and how to submit a manuscript.

I will use myself as an illustration. I am pleased to see that my 2005 article on myocardial ischemia and reperfusion injury continues to receive significant downloads. But why is this article getting more downloads than my more recent article? - Buja LM, Weerasinghe P. Unresolved issues in myocardial reperfusion injury. Cardiovasc Pathol 2010;19:29-35. At the same time, the 2010 article received 5 citations (not all by me) contributing to the 2011 Impact Factor.

I welcome your comments and suggestions on all aspects of the Journal including published content, ideas for invited reviews, and recommendations for reviewers and members of the Editorial Board. And certainly I welcome your submission of your own work for publication in the Journal.

With best regards,

Buja signature

 

L. Maximilian Buja, M.D.

Editor-in-Chief

 

Top Hottest CVP Articles in 2013 - view the most downloaded publications from Cardiovascular Pathology April to June 2013.

Read previous editor pages in the Archives.